Dopamine Reuptake Inhibition Modulates Antidepressant Response, mTor Signaling, and D2R Expression in a Rat Model of Treatment-Resistance
journal contribution
posted on 2016-05-01, 00:00 authored by Rajas R Kale, Abbas KouzaniAbbas Kouzani, Ken WalderKen Walder, Michael BerkMichael Berk, Susannah J TyeBackground: Dopamine plays an important role in antidepressant
treatment-resistance. In the adrenocorticotropic hormone (ACTH)
model of treatment-resistant depression, we therefore assessed the role of dopamine reuptake inhibition on antidepressant response, locomotor activity, mTOR signaling and dopamine D2receptor (D2R) protein expression.
History
Journal
Biological PsychiatryVolume
79Pagination
198S-199SLocation
Philadelphia, Pa.ISSN
0006-3223eISSN
1873-2402Language
engPublication classification
X Not reportable, E3 Extract of paperIssue
9 - 71st Annual Scientific Convention and MeetingPublisher
ElsevierUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineNeurosciencesPsychiatryNeurosciences & NeurologyTreatment-ResistanceACTHDopaminemTORRat110999 Neurosciences not elsewhere classified920410 Mental HealthFaculty of Science Engineering and Built EnvironmentSchool of Engineering3209 Neurosciences420313 Mental health services
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC